Published in Methods Find Exp Clin Pharmacol on January 01, 1982
Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers. Chirality (2000) 1.43
Enzymatic S-methylation of 6-n-propyl-2-thiouracil and other antithyroid drugs. Biochem Pharmacol (1975) 0.99
The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere (2000) 0.96
Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin. Pharm Acta Helv (2000) 0.96
A rapid, sensitive high performance liquid chromatographic method for the determination of meropenem in pharmaceutical dosage form, human serum and urine. Biomed Chromatogr (2001) 0.94
Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives. Antimicrob Agents Chemother (1981) 0.91
The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J Microencapsul (2002) 0.91
Hypoglycemic activity of Artemisia herba alba. J Ethnopharmacol (1988) 0.87
Immunosensors in clinical analysis. Fresenius J Anal Chem (2001) 0.87
Determination of L-pipecolic acid in plasma using chiral liquid chromatography-electrospray tandem mass spectrometry. Clin Chem (2001) 0.83
An improved synthesis and mass fragmentometry of 5-fluoroorotic acid. Acta Pharm Suec (1975) 0.83
Chiral liquid chromatography tandem mass spectrometry in the determination of the configuration of 2-hydroxyglutaric acid in urine. Biomed Chromatogr (2000) 0.82
Synthesis of an active hydroxylated glutethimide metabolite and some related analogs with sedative-hypnotic and anticonvulsant properties. J Med Chem (1975) 0.81
Amperometric biosensors/sequential injection analysis system for simultaneous determination of S- and R-captopril. Biosens Bioelectron (2000) 0.81
Colorimetric determination of clonidine. Arzneimittelforschung (1981) 0.81
Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats. Pharmacology (2002) 0.81
Selenouracil derivatives are potent inhibitors of the selenoenzyme type I iodothyronine deiodinase. Biochem Biophys Res Commun (1992) 0.80
Validated analysis of fluvastatin in a pharmaceutical capsule formulation and serum by capillary electrophoresis. Biomed Chromatogr (2001) 0.80
GLC-mass spectrometry of Teucrium polium oil. J Pharm Sci (1979) 0.80
Mutagenic and antimutagenic factor(s) extracted from a desert mushroom using different solvents. Mutagenesis (1989) 0.79
Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum. Chirality (1999) 0.79
Identification of tamoxifen and metabolites in human male urine by GC/MS. Biomed Chromatogr (2000) 0.79
Flow injection system with chemiluminometric detection for enzymatic determination of ascorbic acid. Luminescence (2000) 0.78
A new construction for a potentiometric, enantioselective membrane electrode--its utilization to the S-captopril assay. Talanta (1999) 0.78
Toxicologic and histopathologic studies of Pleurotus ostreatus mushroom in mice. J Ethnopharmacol (1987) 0.78
Synthesis and pharmacological evaluation of the antifibrillatory effect of fluorinated derivatives of carazolol and celiprolol: comparison with propranolol. Gen Pharmacol (1993) 0.78
Synthesis and antimicrobial activity of novel pyrazolo[3,4-b]quinoline derivatives. Arch Pharm (Weinheim) (2001) 0.77
Ca(2+)-dependent production of reactive oxygen metabolites by human neutrophils in response to fluorinated propranolol analogues. Biochem Pharmacol (2001) 0.77
Application of capillary electrophoresis for the analysis of chiral drugs in biological fluids. Electrophoresis (1997) 0.77
Voltammetric investigation of oxidation of zuclopenthixol and application to its determination in dosage forms and in drug dissolution studies. J Pharm Biomed Anal (2000) 0.77
Simultaneous detection of S and R captopril using sequential injection analysis. Talanta (2000) 0.77
Clarithromycin targeting to lung: characterization, size distribution and in vivo evaluation of the human serum albumin microspheres. Farmaco (2000) 0.77
Chiral derivatization reagents for drug enantioseparation by high-performance liquid chromatography based upon pre-column derivatization and formation of diastereomers: enantioselectivity and related structure. Biomed Chromatogr (2001) 0.77
The effect of absorption enhancers on the initial degradation kinetics of insulin by alpha-chymotrypsin. Int J Pharm (2001) 0.77
Lymphocyte subsets and adhesion molecules expression in heatstroke and heat stress. J Appl Physiol (1985) (1998) 0.77
Glutaraldehyde, gamma-carboxyglutamic acid and calcium in explanted bioprosthetic heart valves. J Heart Valve Dis (1994) 0.76
Determination of melatonin in pharmaceutical formulations and human plasma by gas chromatography-electron impact mass spectrometry. Biomed Chromatogr (1999) 0.76
Amphetamine: a pharmacological profile. Am J Pharm Sci Support Public Health (1972) 0.76
Antioxidant activity of 4-flavonil-1,4-dihydropyridine derivatives. Biopolymers (2001) 0.75
Design and use of electrochemical sensors in enantioselective high throughput screening of drugs. A minireview. Comb Chem High Throughput Screen (2000) 0.75
Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib. Pharmazie (2007) 0.75
Recent chromatographic and electrophoretic enantioseparations of cardiovascular drugs. Biomed Chromatogr (1999) 0.75
Maltodextrins as new chiral selectors in the design of potentiometric, enantioselective membrane electrodes. Fresenius J Anal Chem (2001) 0.75
Inhibition of steroidogenesis in isolated rat adrenal cells by glutethimide congeners. Methods Find Exp Clin Pharmacol (1980) 0.75
Optimization of the chiral separation of some 2-arylpropionic acids on an avidin column by modeling a combined response. Chirality (2001) 0.75
Interaction of potent muta-carcinogenic 2-aminodipyrido-[1,2-a: 3',2'-d]-imidazoles with some target macromolecules by 1H-NMR spectroscopy. Acta Pharm Suec (1988) 0.75
Isomeric specificity of diphenylmethylpiperidine in the production of rat pancreatic islet cell toxicity. Toxicology (1977) 0.75
Synthesis and antimicrobial activity of 4-aza-5alpha-sitostane and the 4-methyl derivative. Pharm Acta Helv (1974) 0.75
Application of the restricted-access precolumn packing material alkyl-diol silica in a column-switching system for the determination of ketoprofen enantiomers in horse plasma. J Chromatogr A (2000) 0.75
Pharmacokinetics and cardiovascular effect of etoricoxib in the absence or presence of St. John's Wort in rats. Arzneimittelforschung (2012) 0.75
Assay of methimazole by n.m.r. spectroscopy. J Pharm Pharmacol (1979) 0.75
Problem with mouse neuroblastoma for iodine-131 MIBG studies. J Nucl Med (1987) 0.75
Periodate oxidimetric determination of nadolol. Pharmazie (1981) 0.75
Simultaneous determination of melatonin and pyridoxine in tablet formulations by differential pulse voltammetry. Pharmazie (2001) 0.75
Spectrophotometric and fluorimetric assay of prazosin hydrochloride in tablet form. Pharmazie (1985) 0.75
Synthesis and cholinergic activity of some structural analogs of pilocarpine. J Med Chem (1973) 0.75
Spectrophotometric determination of tranexamic acid with chloranil. Talanta (1984) 0.75
Enalapril microbial biosensor. Prep Biochem Biotechnol (1998) 0.75
Synthesis and monoamine oxidase inhibitory activity of some pentafluorobenzylidenes and their corresponding hydrazines. Pharm Acta Helv (1980) 0.75
Bioavailability of racemic ketoprofen in healthy horses following rectal administration. Res Vet Sci (1999) 0.75
Mescaline: a pharmacological profile. Am J Pharm Sci Support Public Health (1973) 0.75
High-performance liquid chromatographic determination of clobazam and one of its pharmaceutical formulations. J Pharm Biomed Anal (1987) 0.75
Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA. Biomed Chromatogr (2000) 0.75
Conductimetric determination of methimazole. Pharmazie (1980) 0.75
Comparison of the enantiomeric separation of some 2-arylpropionic acids on a novel Pirkle-concept stationary packing by narrow-bore and conventional liquid chromatography. Biomed Chromatogr (2000) 0.75
Synthesis and pharmacological properties of sulfur analogs of pilocarpine derivatives. Part I. Pharm Acta Helv (1980) 0.75
Synthesis and antiperoxidase activity of propylthiouracil derivatives and metabolites. J Pharm Sci (1974) 0.75
The determination of glutethimide by n.m.r. spectrometry. Anal Chim Acta (1974) 0.75
Determination of aztreonam and L-arginine combination in parenteral formulations. J Assoc Off Anal Chem (1988) 0.75
A rapid sample preparation method for the HPLC determination of the opioid antagonist naltrexone in serum. Pharmazie (1999) 0.75
Enhancing effect of carazolol on chemiluminescence accompanying decomposition of hydrogen peroxide in the presence of copper ions. Pharmazie (1999) 0.75
Fluorometric and spectrophotometric determination of pirbuterol hydrochloride in authentic and dosage forms. J Assoc Off Anal Chem (1986) 0.75
Application of PMR spectrometry in pharmaceutical analysis, IV. Assay of nalidixic acid. Pharm Acta Helv (1981) 0.75
Moclobemide-selective membrane electrode and its pharmaceutical applications. Talanta (1996) 0.75
Structure and pharmacological properties of metapilocarpine--a reinvestigation. Acta Pharm Suec (1974) 0.75
Determination of nabumetone in pharmaceutical formulation by flow injection analysis (FIA) with UV-detection. Pharmazie (2003) 0.75
Spectrofluorometric determination of pindolol and its dosage form. J Assoc Off Anal Chem (1983) 0.75
Colorimetric determination of aztreonam and conductometric determination of L-arginine in injectable form. J Pharm Belg (1989) 0.75
Amperometric biosensor based on D-aminoacid oxidase for the R-perindopril assay. Fresenius J Anal Chem (2000) 0.75
Polarographic determination of butorphanol tartrate. Int J Environ Anal Chem (1983) 0.75
Rapid assay of iopanoic acid in dog plasma using a Hisep column. Biomed Chromatogr (1994) 0.75
DNA strand breaks and mutations caused by penbutolol, a beta blocker. Mutat Res (1988) 0.75
Determination of urinary and serum beta-glucuronidase and alkaline phosphatase in various renal disease and kidney rejection transplanted patients. Prep Biochem Biotechnol (2000) 0.75
S-perindopril assay using a potentiometric, enantioselective membrane electrode. Chirality (1999) 0.75
Spectrophotometric and fluorimetric determination of nomifensine maleate. Talanta (1987) 0.75
Continuous wavelet transformation applied to the simultaneous quantitative analysis of two-component mixtures. Pharmazie (2004) 0.75
Site of glucuronide conjugation to the antithyroid drug 6-n-propyl-2-thiouracil. Biochem Pharmacol (1977) 0.75
Mutagenicity of enantiomers of penbutolol. Drug Chem Toxicol (1989) 0.75
Flow analysis for determination of paraoxon with use of immobilized acetylcholinesterase reactor and new type of chemiluminescent reaction. Biopolymers (2000) 0.75
Direct enantioselective separation of clenbuterol by chiral HPLC in biological fluids. Biomed Chromatogr (1996) 0.75
Colorimetric, spectrophotometric and fluorimetric determination of prenalterol hydrochloride. Analyst (1983) 0.75
Chemical assay of glutaraldehyde incorporation into pericardial tissue. J Heart Valve Dis (1994) 0.75
Biosensors for the enantioselective analysis of S-enalapril and S-ramipril. Prep Biochem Biotechnol (1998) 0.75
Enantioseparation of aminoglutethimide and thalidomide by high performance liquid chromatography or supercritical fluid chromatography on mono-2 and mono-6-O-pentenyl-beta-cyclodextrin-based chiral stationary phases. Biomed Chromatogr (2001) 0.75
Recent applications of chromatographic resolution of enantiomers in pharmaceutical analysis. Biomed Chromatogr (1997) 0.75
Cholesteryl iodide-125I as a diagnostic adrenal photoscanning agent. Part - I. Res Commun Chem Pathol Pharmacol (1979) 0.75
In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs. Chirality (1994) 0.75
An enantioselective assay for (+/-)-modafinil. J Pharm Biomed Anal (2001) 0.75
Direct HPLC analysis of ketoprofen in horse plasma applying an ADS-restricted access-phase. Biomed Chromatogr (1999) 0.75
Conformational flexibility of cyclohexylaminoglutethimide: a potent aromatase inhibitor. Comparison of the three configurations of the cyclohexyl moiety. Cancer Lett (1994) 0.75